BKM-1644

N/A

Report date: 2025/01/26 18:52:09
NME

Base Information

Drug NameBKM-1644
Drug Alias NameBKM-1644
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetCure Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesMetCure Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsBone metastases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A